Highlights and Quick Summary
- Depreciation & Amortization Growth for the quarter ending September 30, 2022 was -85.16% (a -231.89% decrease compared to previous quarter)
- Year-over-year quarterly Depreciation & Amortization Growth decreased by -191.65%
- Annual Depreciation & Amortization Growth for 2021 was 51.99% (a -40.84% decrease from previous year)
- Annual Depreciation & Amortization Growth for 2020 was 87.88% (a -70.45% decrease from previous year)
- Annual Depreciation & Amortization Growth for 2019 was 297.38% (a -94.88% decrease from previous year)
- Twelve month Depreciation & Amortization Growth ending September 30, 2022 was 38.37% (a -46.91% decrease compared to previous quarter)
- Twelve month trailing Depreciation & Amortization Growth decreased by -26.2% year-over-year
Trailing Depreciation & Amortization Growth for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 38.37% | 72.28% | 67.8% | 51.99% |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation & Amortization Growth of Beam Therapeutics Inc.
Most recent Depreciation & Amortization Growthof BEAM including historical data for past 10 years.Interactive Chart of Depreciation & Amortization Growth of Beam Therapeutics Inc.
Beam Therapeutics Inc. Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -85.16% | 64.57% | 106.79% | – |
| 2021 | 92.92% | 25.82% | 41.11% | 45.52% | 51.99% |
| 2020 | 78.32% | 140.53% | 122.43% | 32.11% | 87.88% |
| 2019 | 15.69% | -58.42% | -55.04% | -24.3% | 297.38% |
| 2018 | – | – | – | -13.56% | 5809.09% |
| 2017 | – | – | – | – | -98.31% |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology